Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2015 | 71 | 04 |

Tytuł artykułu

Strategia zwalczania choroby niebieskiego języka w Europie


Warianty tytułu

Bluetongue control strategy in Europe

Języki publikacji



The article reviews the policy of bluetongue (BT) control in Europe until 2000 and the new strategy adopted in November this year. The control strategy applied until 2000 was consistent with the Directive 92/119/EEC of 17 December 1992, which involved the use of direct control methods, such as the demarcation of a 3-km radius protection zone and a 10-km radius surveillance zone around each infected farm, as well as the slaughter of all susceptible animals on the infected farm and possibly on neighboring farms. This strategy was modified in the autumn of 2000 by the Directive 2000/75/EC, as it became obvious that the stamping-out approach was completely inadequate in dealing with vector-borne diseases, such us bluetongue or epizootic hemorrhagic disease (EHD). According to this directive, the primary strategy for BT control should be based on the strict control of the transfer of susceptible animals from zones considered infected and on vaccination in the protection zone. The areas subject to movement restrictions are defined on the basis of intensive clinical, serological and entomological surveillance. Moreover, a strict quarantine of animals and herds is applied, as well as a safe utilization of dead animals and disinfection of animals, buildings and environment with insecticides. By the Commission Decision 2008/655/WE, the strategy for BT control also includes vaccinations aimed at reducing the spread of the virus in the environment, and measures to ensure safe movement of susceptible animals between affected and free zones. A BT control policy that combines administrative methods with prophylactic vaccination of all susceptible animals, supplemented by the application of insecticides to control Culicoides midges in the environment, is currently the most effective strategy for BT eradication.








Opis fizyczny



  • Zakład Pryszczycy, Państwowy Instytut Weterynaryjny - Państwowy Instytut Badawczy w Puławach, ul.Wodna 7, 98-220 Zduńska Wola


  • 1. Anderson J., Hagglund S., Breard E., Comtet L., Lovgren Bengtsson K., Pringle J., Zientara S., Valarcher J. F.: Evaluation of the immunogenicity ofan experimental subunit vaccine that allows differentiation between infectedand vaccinated animals against bluetongue virus serotype 8 in cattle. Clin.Vaccine Immunol. 2013, 20, 1115-1122.
  • 2. Baldet T., Delecolle J. C., Mathieu B., de La Rocque S., Roger F.: Entomological surveillance of bluetongue in France in 2002. Vet. Ital. 2004, 40,226-231.
  • 3. Chaignat V., Worwa G., Scherrer N., Hilbe M., Ehrensperger F., Batten C., Cortyen M., Hofmann M., Thuer B.: Toggenburg Orbivirus, a new bluetonguevirus: initial detection, first observation in field and experimental infection ofgoats and sheep. Vet. Microbiol. 2009, 138, 11-19.
  • 4. Clercq K. de, Mertens P., De Leeuw I., Oura C., Houdart P., Potgieter A. C., Maan S., Hooyberghs J., Batten C., Vandemeulebroucke E., Wright I. M., MaanN., Riocreux F., Sanders A., Vanderstede Y., Nomikou K., Raemaekers M., Bin-Tarif A., Shaw A., Henstock M., Breard E., Dubois E., Gastaldi-Thiery C.,Zientara S., Verheyden B., Vandenbussche F.: Emergence of bluetongueserotypes in Europe, part 2: the occurrence of a BTV-11 strain in Belgium.Transbound. Emerg. Dis. 2009, 56, 355-361.
  • 5. Doherty W. M., Bishop A. L., Melville L. F., Johnson S. J., Bellis G. A., Hunt N. T.: Protection of cattle from Culicoides spp. in Australia by shelter andchemical treatments. Vet. Ital. 2004, 40, 320-323.
  • 6. Dungu B., Gerdes T., Smit T.: The use of vaccination in the control of bluetongue in southern Africa. Vet. Ital. 2004, 40, 616-622.
  • 7. Emidio B. di, Nicolussi P., Patta C., Ronchi G. F., Monaco F., Savini G., Ciarelli A., Caporale V.: Efficacy and safety studies on an inactivated vaccineagainst bluetongue virus serotype 2. Vet. Ital. 2004, 40, 640-644.
  • 8. Erasmus B. J.: Bluetongue in sheep and goats. Aust. Vet. J. 1975, 51, 165-170.
  • 9. Giovannini A., Calistri P., Conte A., Savini L., Nannini D., Patta C., Santucci U., Caporale V.: Bluetongue virus surveillance in a nevly infected area. Vet. Ital.2004, 40, 188-197.
  • 10. Maan N. S., Maan S., Belaganahalli M. N., Ostlund E. N., Johnson D. J., Nomikou K., Mertens P. P.: Identification and differentiation of the twentysix bluetongue virus serotypes by RT-PCR amplification of the serotype-specificgenome segment 2. PLoS One 2012, 7, e32601. doi. 10.1371/journal.pone.0032601.
  • 11. Maan S., Maan N. S., Nomikou K., Batten C., Antony F., Belaganahalli M. N., Samy A. M., Reda A. A., Al-Rashid S. A., El Batel M., Oura C. A., MertensP. P.: Novel bluetongue virus serotype from Kuwait. Emerg. Infect. Dis. 2011,17, 886-889.
  • 12. MacLachlan N. J.: Bluetongue: pathogenesis and duration of viraemia. Vet. Ital. 2004, 40, 462-467.
  • 13. MacLachlan N. J.: The pathogenesis and immunology of bluetongue virus infection of ruminants. Comp. Immunol. Microbiol. Infect. Dis. 1994, 17,197-206.
  • 14. Mellor P. S., Boorman J.: The transmission and geographical spread of African horse sickness and bluetongue viruses. Ann. Trop. Med. Parasitol. 1995, 89,1-15.
  • 15. Mellor P. S., Boorman J., Baylis M.: Culicoides bitting midges: their role as arbovirus vectors. Annu. Rev. Entomol. 2000, 45, 307-340.
  • 16. Mellor P. S., Wittmann E. J.: Bluetongue virus in the Mediterranean Basin 1998-2001. Vet. J. 2002, 164, 20-37.
  • 17. Mertens P. P. C., Maan N. S., Prasad G., Samuel A. R., Shaw A. E., Potgieter A. C., Anthony S. J., Maan S.: Design of primers and use of RT-PCR assaysfor typing European bluetongue virus isolates: differentiation of field andvaccine strains. J. Gen. Virol. 2007, 88, 2811-2823.
  • 18. Mintiens K., Meroc E., Faes C., Abrahantes J. C., Hendrickx G., Staubach C., Gerbier G., Elbers A. R., Aerts M., De Clercq K.: Impact of human interventionson the spread of bluetongue virus serotype 8 during the 2006 epidemicin north-western Europe. Prev. Vet. Med. 2008, 87, 145-161.
  • 19. Monaco F., Bonfini B., Zaghini M., Antonucci D., Pini A., Savini G.: Vaccination of cattle using monovalent modified-live vaccine against bluetongue virusserotype 2: innocuity, immunogenicity, and effect on pregnancy. Vet. Ital.2004, 40, 671-675.
  • 20. Panagiotatos D. E.: Regional overview of bluetongue viruses vectors, surveillance and unique features in Eastern Europe between 1998 and 2003. Vet.Ital. 2004, 40, 61-72.
  • 21. Patta C., Giovannini A., Rolesu S., Nannini D., Savini G., Calistri P., Santucci U., Caporale V.: Bluetongue vaccination in Europe: the Italianexperience. Vet. Ital. 2004, 40, 601-610.
  • 22. Rodriquez-Sanchez B., Iglesias-Martin I., Martinez-Aviles M., Sanchez- Vizcaino J. M.: Orbiviruses in the Mediterranean basin: updated epidemiological situation of bluetongue and new methods for the detection of BTV serotype 4. Transbound. Emerg. Dis. 2008, 55, 205-214.
  • 23. Savini G., MacLachlan N. J., Sanchez-Vizcaino J. M., Zientara S.: Vaccines against bluetongue in Europe. Comp. Immunol. Microbiol. Infect. Dis. 2008,31, 101-120.
  • 24. Savini G., Monaco F., Facchinei A., Pinoni C., Salucci S., Cofini F., Di Ventura M.: Field vaccination of sheep with bivalent modified-live vaccineagainst bluetongue virus serotypes 2 and 9: effect on milk production. Vet.Ital. 2004, 40, 627-630.
  • 25. Schwartz-Cornil I., Mertens P. P., Contreras V., Hemati B., Pascale F., Breard E., Mellor P. S., MacLachlan N. J., Zientara S.: Bluetongue virus: virology, pathogenesis and immunity. Vet. Res. 2008, 39, 46. doi: 10.1051/ vetres:2008023.
  • 26. Verwoerd D. W., Erasmus B. J.: Bluetongue, [w:] Tustin R. C., Coetzer J. A. (eds.): Infectious disease of livestock. Oxford University Press, Cape Town2004, s. 1201-1220.
  • 27. Wilson A., Carpenter S., Gloster J., Mellor P.: Re-emergence of bluetongue in northern Europe in 2007. Vet. Rec. 2007, 161, 487-489.
  • 28. Wilson A., Mellor P.: Bluetongue in Europe: vectors, epidemiology and climate change. Parasitol. Res. 2008, 103, S69-S77.
  • 29. Wilson A. J., Mellor P. S.: Bluetongue in Europe: past, present and future. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 2009, 364, 2669-2681.
  • 30. Zientara S., MacLachlan N. J., Calistri P., Sanchez-Vizcaino J. M., Savini G .:Bluetongue vaccination in Europe. Expert Rev. Vaccines 2010, 9, 989-991.

Typ dokumentu



Identyfikator YADDA

JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.